Related Experiment Video
Updated: Jun 23, 2026

03:53
Extracellular Vesicle Tissue Factor Activity Assay
Published on: December 29, 2023
Tissue factor and factor v involvement in rat peritoneal fibrosis
Hiroki Saito1, Masayuki Kitamoto, Kozue Kato
1Division of Molecular Medicine, University of Shizuoka School of Pharmaceutical Sciences, Shizuoka, Japan.
Summary
Tissue factor and factor V expression in macrophages contribute to peritoneal fibrosis by promoting blood vessel growth and extracellular matrix buildup. Inhibiting factor Xa may reduce these fibrotic changes.
Area of Science:
- Nephrology
- Pathology
- Biochemistry
Background:
- Long-term peritoneal dialysis can lead to fibrin deposition and peritoneal fibrosis.
- The roles of tissue factor and factor V in this process are not fully understood.
Purpose of the Study:
- To investigate the contribution of tissue factor and factor V to peritoneal fibrosis.
- To explore the potential of factor Xa inhibition as a therapeutic strategy.
Main Methods:
- Wistar rats received daily intraperitoneal injections of chlorhexidine gluconate (CG) for 28 days.
- A factor Xa inhibitor, fondaparinux, was administered subcutaneously in a subset of rats.
- Peritoneal tissues were analyzed using immunohistochemistry and in situ hybridization.
Main Results:
- CG injection significantly thickened the peritoneal submesothelial compact zone in a dose-dependent manner.
- Massive deposition of fibrin, fibronectin, and type IV collagen was observed in CG-injected rats.
- Intense staining for tissue factor, factor V, factor X, and protease-activated receptor-2 was noted in macrophages within the fibrotic peritoneum.
- Fondaparinux treatment reduced peritoneal fibrosis and angiogenesis.
Conclusions:
- Tissue factor and factor V expression in macrophages, along with factor X deposition, likely drive peritoneal fibrosis.
- These factors may promote angiogenesis and extracellular matrix accumulation through profibrotic and procoagulant mechanisms.
- Factor Xa inhibition shows promise in mitigating peritoneal fibrosis.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
